Mixtard 30 Mg Flexpen

Mixtard 30 FlexPen 100 IU/ml – Premixed Human Insulin for Diabetes Management

Mixtard 30 FlexPen 100 IU/ml is a prescription premixed human insulin used to help control blood glucose levels in patients with diabetes mellitus. It contains 30% soluble human insulin, which acts relatively quickly, and 70% isophane human insulin, which provides a longer-lasting effect. Mixtard 30 begins lowering blood glucose approximately 30 minutes after injection, while its overall effect may continue for up to approximately 24 hours. It is supplied in a disposable, pre-filled FlexPen containing 3 ml of insulin suspension. The insulin dose and injection schedule must be determined by a qualified healthcare professional based on blood glucose readings, diet, physical activity, other medicines, and individual insulin requirements.

Key Features

• Premixed Human Insulin: Combines fast-acting and intermediate-acting human insulin.
• 30/70 Formulation: Contains 30% soluble insulin and 70% isophane insulin.
• 100 IU/ml Strength: Each millilitre contains 100 international units of human insulin.
• Pre-Filled FlexPen: Ready-to-use disposable insulin-injection pen.
• Adjustable Dose: Delivers 1 to 60 units in increments of one unit.
• Subcutaneous Administration: Designed for injection beneath the skin.

Active Ingredients

• Soluble Human Insulin 30%: Provides the faster-acting component of the formulation.
• Isophane Human Insulin 70%: Provides the longer-acting component for continued blood glucose control.

Uses

• Management of diabetes mellitus requiring insulin treatment.
• Blood glucose control in eligible patients with type 1 diabetes.
• Blood glucose control in eligible patients with type 2 diabetes.
• Used as part of an individualized diabetes-management plan that includes appropriate diet, activity, and glucose monitoring.

How to Prepare the FlexPen

• Check the product name, insulin type, concentration, and expiry date before every injection.
• Allow a new refrigerated pen to reach room temperature before preparing it.
• Before using a new pen for the first time, move the pen up and down 20 times so the glass ball moves from one end of the cartridge to the other.
• Before each subsequent injection, move the pen up and down at least 10 times.
• Continue mixing until the insulin appears uniformly white and cloudy.
• Do not use the pen if the suspension does not become uniformly white and cloudy.
• Ensure that at least 12 units remain in the cartridge so the insulin can be mixed correctly.
• Attach a new compatible NovoFine or NovoTwist disposable needle before every injection.
• Perform an insulin-flow check according to the FlexPen instructions before selecting the prescribed dose.

How to Use

• Use Mixtard 30 FlexPen exactly as prescribed by your healthcare professional.
• Inject it under the skin of the abdomen, thigh, buttock, or upper arm.
• Rotate injection sites within the selected body area to reduce the risk of skin lumps, thickening, or pitting.
• Mixtard is generally administered approximately 30 minutes before a meal.
• Eat a meal or a carbohydrate-containing snack within 30 minutes after the injection.
• Press the dose button completely and keep the needle under the skin for at least six seconds.
• Remove and safely discard the needle after every injection.
• Do not change the dose, insulin type, or injection schedule without medical supervision.

Precautions

• Do not use Mixtard during an episode of low blood glucose.
• Check blood glucose regularly according to your diabetes-management plan.
• Inform your doctor if you have kidney, liver, adrenal, thyroid, or pituitary problems.
• Changes in meals, physical activity, illness, stress, body weight, or other medicines may alter insulin requirements.
• Tell your healthcare provider about all diabetes medicines, prescription medicines, supplements, and herbal products you use.
• Always carry a source of fast-acting sugar as advised by your healthcare provider.
• Do not share the FlexPen or needles with another person, even when the needle has been changed.
• Do not use Mixtard in an insulin-infusion pump.
• Do not inject it directly into a vein or muscle.

Warning

• Hypoglycaemia: Low blood glucose is the most common adverse effect and may become severe or life-threatening.
• Symptoms may include sweating, shaking, hunger, dizziness, headache, confusion, blurred vision, weakness, seizures, or unconsciousness.
• Hyperglycaemia: Missing doses, using insufficient insulin, illness, or device problems may cause dangerously high blood glucose.
• Allergic Reactions: Seek urgent medical help for breathing difficulty, facial swelling, widespread rash, dizziness, or rapid heartbeat.
• Using the wrong insulin or selecting an incorrect dose may cause severe blood glucose complications.
• Do not use the FlexPen if it is damaged, leaking, frozen, or not functioning correctly.

Common Side Effects

• Low blood glucose.
• Injection-site pain, redness, itching, or swelling.
• Skin thickening, pits, or lumps at repeatedly used injection sites.
• Weight gain.
• Temporary swelling caused by fluid retention.
• Temporary vision changes when insulin treatment is started or adjusted.

Storage

• Before first use, store in a refrigerator between 2°C and 8°C.
• Keep away from the refrigerator cooling element.
• Do not freeze and do not use the pen if it has been frozen.
• During use or when carried as a spare, store below 30°C for a maximum of six weeks.
• Do not refrigerate an in-use FlexPen.
• Keep the pen cap attached to protect the insulin from light.
• Protect from excessive heat and direct sunlight.
• Store without a needle attached.
• Keep out of reach of children.

Legal Disclaimer: Mixtard 30 FlexPen 100 IU/ml is a prescription insulin medicine intended for use under the supervision of a qualified healthcare professional. Incorrect dosing, missed meals, or improper administration may cause severe hypoglycaemia or hyperglycaemia. This information is provided for educational purposes only and should not replace professional medical advice, diabetes training, blood glucose monitoring, or the instructions supplied with the medicine.